Why Australian Pharmaceutical Industries Ltd shares are falling on its half-year results

Investors have reacted to disappointing results for the half-year to February 28 2018 for health and beauty services company Australian Pharmaceutical Industries Ltd (ASX: API), with its share price down 2% to $1.47 at the time of writing.

Australian Pharmaceutical Industries reported a drop in statutory NPAT of 14.4% to $24.9 million, with revenue flat at $2 billion and dividends maintained at 3.5c per share fully-franked.

Share prices for Australian Pharmaceutical have been volatile in the past 12 months, trending down from $2.03 at this time last year.

The company blames “suppressed retail conditions” for the drop in earnings, and similar conditions have affected others in the sector, with peer Mayne Pharma Group Ltd (ASX: MYX) reporting a 17% decrease in revenue, 82% drop in reported EBITDA and a net loss after tax of $174.2 million for the six months to December 31, 2018.

Elsewhere in the healthcare sector Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) shares could be in buy territory as Ramsay ploughs ahead on its global expansion strategy.

Healthscope Ltd (ASX: ASX: HSO) is also one to watch with its pathology services business going great guns.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!